| Low-dose irradiation programs macrophage differentiation to an iNOS+/M1 phenotype that orchestrates effective T cell immunotherapy F Klug, H Prakash, PE Huber, T Seibel, N Bender, N Halama, C Pfirschke, ... Cancer cell 24 (5), 589-602, 2013 | 991 | 2013 |
| A vaccine targeting mutant IDH1 induces antitumour immunity T Schumacher, L Bunse, S Pusch, F Sahm, B Wiestler, J Quandt, O Menn, ... Nature 512 (7514), 324-327, 2014 | 763 | 2014 |
| Classification of current anticancer immunotherapies L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ... Oncotarget 5 (24), 12472, 2014 | 547 | 2014 |
| Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy N Halama, S Michel, M Kloor, I Zoernig, A Benner, A Spille, ... Cancer research 71 (17), 5670-5677, 2011 | 471 | 2011 |
| Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells R Carretero, IM Sektioglu, N Garbi, OC Salgado, P Beckhove, ... Nature immunology 16 (6), 609-617, 2015 | 456 | 2015 |
| Bone marrow as a priming site for T-cell responses to blood-borne antigen M Feuerer, P Beckhove, N Garbi, Y Mahnke, A Limmer, M Hommel, ... Nature medicine 9 (9), 1151-1157, 2003 | 391 | 2003 |
| Myeloid cells and related chronic inflammatory factors as novel predictive markers in melanoma treatment with ipilimumab C Gebhardt, A Sevko, H Jiang, R Lichtenberger, M Reith, K Tarnanidis, ... Clinical Cancer Research 21 (24), 5453-5459, 2015 | 370 | 2015 |
| Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow M Feuerer, P Beckhove, L Bai, EF Solomayer, G Bastert, IJ Diel, C Pedain, ... Nature medicine 7 (4), 452-458, 2001 | 364 | 2001 |
| Differentiation therapy exerts antitumor effects on stem-like glioma cells B Campos, F Wan, M Farhadi, A Ernst, F Zeppernick, KE Tagscherer, ... Clinical Cancer Research 16 (10), 2715-2728, 2010 | 350 | 2010 |
| Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-β J Lohr, T Ratliff, A Huppertz, Y Ge, C Dictus, R Ahmadi, S Grau, N Hiraoka, ... Clinical Cancer Research 17 (13), 4296-4308, 2011 | 349 | 2011 |
| Significance of heparanase in cancer and inflammation I Vlodavsky, P Beckhove, I Lerner, C Pisano, A Meirovitz, N Ilan, M Elkin Cancer microenvironment 5, 115-132, 2012 | 280 | 2012 |
| Randomized, controlled trial of resistance training in breast cancer patients receiving adjuvant radiotherapy: results on cancer-related fatigue and quality of life K Steindorf, ME Schmidt, O Klassen, CM Ulrich, J Oelmann, ... Annals of oncology 25 (11), 2237-2243, 2014 | 267 | 2014 |
| Pancreatic cancer microenvironment J Kleeff, P Beckhove, I Esposito, S Herzig, PE Huber, JM Löhr, H Friess International journal of cancer 121 (4), 699-705, 2007 | 264 | 2007 |
| Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model A Sevko, T Michels, M Vrohlings, L Umansky, P Beckhove, M Kato, ... The Journal of Immunology 190 (5), 2464-2471, 2013 | 259 | 2013 |
| The significant role of mast cells in cancer K Khazaie, NR Blatner, MW Khan, F Gounari, E Gounaris, K Dennis, ... Cancer and Metastasis Reviews 30 (1), 45-60, 2011 | 259 | 2011 |
| Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome Y Ge, C Domschke, N Stoiber, S Schott, J Heil, J Rom, M Blumenstein, ... Cancer immunology, immunotherapy 61, 353-362, 2012 | 249 | 2012 |
| Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit HH Steiner, MM Bonsanto, P Beckhove, M Brysch, K Geletneky, R Ahmadi, ... Journal of Clinical Oncology 22 (21), 4272-4281, 2004 | 239 | 2004 |
| Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma A Bonertz, J Weitz, DHK Pietsch, NN Rahbari, C Schlude, Y Ge, ... The Journal of clinical investigation 119 (11), 3311-3321, 2009 | 234 | 2009 |
| Exploiting the glioblastoma peptidome to discover novel tumour-associated antigens for immunotherapy V Dutoit, C Herold-Mende, N Hilf, O Schoor, P Beckhove, J Bucher, ... Brain 135 (4), 1042-1054, 2012 | 226 | 2012 |
| Restricting glycolysis preserves T cell effector functions and augments checkpoint therapy K Renner, C Bruss, A Schnell, G Koehl, HM Becker, M Fante, ... Cell reports 29 (1), 135-150. e9, 2019 | 225 | 2019 |
